We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Monoclonal Antibody Blocks Pro-Life Molecular Signaling in Pancreatic Tumors

By LabMedica International staff writers
Posted on 29 Jul 2013
A monoclonal antibody that selectively binds to connective tissue growth factor (CTGF) slows the progress of pancreatic tumors by decreasing the activity of XIAP (X-linked inhibitor of apoptosis), a protein that promotes cancer cell survival.

CTGF causes a variety of cellular responses including reduced cell adhesion and enhanced cell migration and proliferation. More...
CTGF has also been shown to be essential for epithelial to mesenchymal transition (EMT), a process whereby normal functioning cells morph into ones that produce mainly scar tissue (of which collagen in the major protein component). Cellular responses to CTGF also have effects at the tissue level including remodeling, formation of new blood vessels (angiogenesis), changes in blood vessel architecture (permeability and stiffness), and replacement of normal tissue with scar tissue.

Treatment of pancreatic ductal adenocarcinoma (PDA) is hampered by poor tissue perfusion that restricts the amount of drug able to reach the tumor. Furthermore, cells in the tumor microenvironment produce molecules, such as CTGF, that provide "pro-life" cues that promote drug resistance in the cancer cells.

Investigators at Cold Spring Harbor Laboratory (NY, USA) used a mouse pancreatic cancer model to study the impact on tumor growth caused by the interaction between CTGF and Fibrogen Inc.'s (San Francisco, CA, USA) CTGF-specific monoclonal antibody, FG-3019.

They reported in the July 8, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that pancreatic tumors in mice treated with FG-3019 in combination with the chemotherapeutic drug gemcitabine stopped growing. The response to FG-3019 correlated with the decreased expression of a previously described promoter of chemotherapy resistance, the X-linked inhibitor of apoptosis protein.

"In addition to drug delivery being a problem, there is also this nurturing aspect that prevents cancer cells responding to the drugs," said senior author Dr. David A. Tuveson, professor of medical oncology at Cold Spring Harbor Laboratory. "Both CTGF and XIAP have been shown to be present in human pancreatic cancer tumors so combination therapy using antagonists of either molecule could be a feasible approach."

Related Links:

Cold Spring Harbor Laboratory
Fibrogen Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.